Evidence map›Paper›PMID 38055769›Full record

ArticlePLoS computational biology2023

Major depressive disorder and bistability in an HPA-CNS toggle switch.

Ben Ron Mizrachi, Avichai Tendler, Omer Karin, Tomer Milo, Dafna Haran, Avi Mayo, Uri Alon

Open access · goldAbstract read
In one paragraph

Article in PLoS computational biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ben Ron MizrachiDept. Molecular Cell biology, Weizmann Institute of Science, Rehovot, Israel.
Avichai TendlerDept. Molecular Cell biology, Weizmann Institute of Science, Rehovot, Israel.
Omer KarinDept. Molecular Cell biology, Weizmann Institute of Science, Rehovot, Israel.
Tomer MiloDept. Molecular Cell biology, Weizmann Institute of Science, Rehovot, Israel.
Dafna HaranDept. Molecular Cell biology, Weizmann Institute of Science, Rehovot, Israel.
Avi MayoDept. Molecular Cell biology, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0002-4479-3423
Uri AlonDept. Molecular Cell biology, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0003-1121-5907
Weizmann Institute of Science · IL

Funding

European Research Council
6 · The paper itself

Abstract

Major depressive disorder (MDD) is the most common psychiatric disorder. It has a complex and heterogeneous etiology. Most treatments take weeks to show effects and work well only for a fraction of the patients. Thus, new concepts are needed to understand MDD and its dynamics. One of the strong correlates of MDD is increased activity and dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis which produces the stress hormone cortisol. Existing mathematical models of the HPA axis describe its operation on the scale of hours, and thus are unable to explore the dynamic on the scale of weeks that characterizes many aspects of MDD. Here, we propose a mathematical model of MDD on the scale of weeks, a timescale provided by the growth of the HPA hormone glands under control of HPA hormones. We add to this the mutual inhibition of the HPA axis and the hippocampus and other regions of the central nervous system (CNS) that forms a toggle switch. The model shows bistability between euthymic and depressed states, with a slow timescale of weeks in its dynamics. It explains why prolonged but not acute stress can trigger a self-sustaining depressive episode that persists even after the stress is removed. The model explains the weeks timescale for drugs to take effect, as well as the dysregulation of the HPA axis in MDD, based on gland mass changes. This understanding of MDD dynamics may help to guide strategies for treatment.

Indexed as

Major Depressive DisorderHumansHydrocortisoneHypothalamo-Hypophyseal SystemPituitary-Adrenal SystemHydrocortisone

Identifiers

PMID38055769
PMCPMC10699645
OpenAlexW4389385276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.